Metabolic profiling reveals reprogramming of lipid metabolic pathways in treatment of polycystic ovary syndrome with 3-iodothyronamine.

Physiol Rep · 2017 · PMC5256158 · PMID 28082426

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

moderately significantno p-value reported

A * P < 0.05 was set to significant and ** P < 0.1 was considered moderately significant, where n = 4.

also in 2,174 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.